CenterBook Partners’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.88M Buy
+127,674
New +$4.04M 0.26% 105
2024
Q2
Sell
-25,058
Closed -$842K 393
2024
Q1
$842K Buy
25,058
+7,531
+43% +$253K 0.06% 322
2023
Q4
$584K Sell
17,527
-19,342
-52% -$624K 0.07% 311
2023
Q3
$1.16M Buy
36,869
+16,170
+78% +$509K 0.14% 231
2023
Q2
$656K Sell
20,699
-1,395
-6% -$45.1K 0.08% 305
2023
Q1
$730K Buy
22,094
+2,734
+14% +$89.6K 0.1% 276
2022
Q4
$623K Sell
19,360
-4,664
-19% -$159K 0.1% 254
2022
Q3
$858K Buy
24,024
+8,471
+54% +$352K 0.17% 210
2022
Q2
$639K Buy
15,553
+8,852
+132% +$430K 0.14% 252
2022
Q1
$388K Buy
6,701
+1,306
+24% +$71.4K 0.14% 247
2021
Q4
$317K Buy
+5,395
New +$327K 0.19% 195

Other funds holding ATEX

CenterBook Partners's ATEX Position: Q1 2026 in Review

CenterBook Partners opened a new position in Anterix (ATEX) in Q1 2026: 127,674 shares worth $4.88M. The stake represents 0.26% of the portfolio and ranks #105 among its holdings. This is a return to the name: CenterBook Partners previously reported a position in ATEX as recently as Q1 2024.

CenterBook Partners first reported a position in ATEX in Q4 2021 and has held it in 11 quarters since. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • CenterBook Partners held 127,674 shares of Anterix worth $4.88M as of Q1 2026.
  • Anterix was a new CenterBook Partners position in Q1 2026.
  • Anterix made up 0.26% of CenterBook Partners's portfolio in Q1 2026, its #105 holding.
  • CenterBook Partners first reported a position in Anterix in Q4 2021 and has held it in 11 quarters since.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on CenterBook Partners's 13F filing for Q1 2026, filed 5 May 2026.